The Japanese government is bracing for a flood of damage suits from hundreds of people who contracted hepatitis B through mandatory childhood vaccinations.
Lawyers for the victims say the first suits will be filed in late March by a group of some 20 people who are seeking compensation of between $139 million and $555 million each, Kyodo News reported Monday.
Other groups are expected to follow in April, filing their cases in 11 district courts across Japan, the lawyers say.
Last month the Diet enacted relief measures for people who contracted hepatitis C from tainted blood products after Japan's Supreme Court ordered compensation for five hepatitis B victims, Kyodo said.
Japan no longer mandates vaccinations against certain diseases due to side effects that prompted a number of lawsuits.
Copyright 2008 by United Press International
Related stories:
Japanese court rules for vaccinated men
Japan's Supreme Court ordered the government to pay 27.5 million yen because five men became gravely ill after completing a mandatory vaccination program.
Hepatitis B exposure may increase risk for pancreatic cancer
In a first-of-its-kind finding, researchers at The University of Texas M. D. Anderson Cancer Center have discovered that exposure to the hepatitis B virus (HBV) may increase the risk of pancreatic cancer.
New approach, old drug show promise against hepatitis C, research shows
The fight against the liver disease hepatitis C has been at something of an impasse for years, with more than 150 million people currently infected, and traditional antiviral treatments causing nasty side effects and often falling short of a cure. Using a novel technique, medical and engineering researchers at Stanford University have discovered a vulnerable step in the virus' reproduction process that in lab testing could be effectively targeted with an obsolete antihistamine.
Nano vaccine for hepatitis B shows promise for third world
Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. The disease and its complications cause an estimated 1 million deaths globally each year.
Structure of hepatitis B virus mapped
Using a newly developed method, Utrecht University researchers have mapped the structure and composition of the hepatitis B virus. The researchers were able to map the structure by spraying the virus.
Improved culture system for hepatitis C virus infection
A University of California, San Diego School of Medicine researcher has developed the first tissue culture of normal, human liver cells that can model infection with the Hepatitis C virus (HCV) and provide a realistic environment to evaluate possible treatments. The novel cell line, described in the July 16 issue of
PLoS ONE, will allow pharmaceutical companies to effectively test new drug candidates or possible vaccines for the HCV infection, which afflicts about 170 million people worldwide. Currently, there is no animal model that is effective for testing such therapies.
Excavated Jericho bones may help researchers combat tuberculosis
Six-thousand year old bones excavated in Jericho may help a joint Israeli-Palestinian-German research group combat tuberculosis.
Hepatitis C virus may need enzyme's help to cause liver disease
A key enzyme may explain how hepatitis C infection causes fatty liver – a buildup of excess fat in the liver, which can lead to life-threatening diseases such as cirrhosis and liver cancer, report University of Pittsburgh Graduate School of Public Health and School of Medicine researchers.